Author:
Kow Chia Siang,Hasan Syed Shahzad,Wong Pei Se,Verma Rohit Kumar
Abstract
Abstract
Objectives
This study aimed to assess the rate of concordance, and to investigate sources of non-concordance of recommendations in the management of hypertension across CPGs in Southeast Asia, with internationally reputable clinical practice guidelines (CPGs).
Methods
CPGs for the management of hypertension in Southeast Asia were retrieved from the websites of the Ministry of Health or cardiovascular specialty societies of the individual countries of Southeast Asia during November to December 2020. The recommendations for the management of hypertension specified in the 2017 American College of Cardiology (ACC)/American Heart Association (AHA) guideline and the 2018 European Society of Cardiology (ESC)/European Society of Hypertension (ESH) guideline were selected to be the reference standards; the recommendations concerning the management of hypertension in the included CPGs in Southeast Asia were assessed if they were concordant with the reference recommendations generated from both the 2017 ACC/AHA guideline and the 2018 ESC/ESH guideline, using the population (P)-intervention (I)-comparison (C) combinations approach.
Results
A total of 59 reference recommendations with unique and unambiguous P-I-C specifications was generated from the 2017 ACC/AHA guideline. In addition, a total of 51 reference recommendations with unique and unambiguous P-I-C specifications was generated from the 2018 ESC/ESH guideline. Considering the six included CPGs from Southeast Asia, concordance was observed for 30 reference recommendations (50.8%) out of 59 reference recommendations generated from the 2017 ACC/AHA guideline and for 31 reference recommendations (69.8%) out of 51 reference recommendations derived from the 2018 ESC/ESH guideline.
Conclusions
Hypertension represents a significant issue that places health and economic strains in Southeast Asia and demands guideline-based care, yet CPGs in Southeast Asia have a high rate of non-concordance with internationally reputable CPGs. Concordant recommendations could perhaps be considered a standard of care for hypertension management in the Southeast Asia region.
Funder
Institute for Research, Development, and Innovation of International Medical University
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference53 articles.
1. World Health Organization (WHO). Global status report on noncommunicable diseases 2014. Geneva: World Health Organization; 2014.
2. Institute for Public Health. National Health and Morbidity Survey (NHMS) 2019: Non-communicable diseases, healthcare demand, and health literacy—Key Findings. Shah Alam: National Institutes of Health; 2020.
3. Kario K, Tomitani N, Buranakitjaroen P, et al. Home blood pressure control status in 2017–2018 for hypertension specialist centers in Asia: results of the Asia BP@Home study. J Clin Hypertens (Greenwich). 2018;20(12):1686–95.
4. Ong SK, Kahan SZ, Lai DTC, et al. Prevalence of undetected hypertension and its association with socio-demographic and non-communicable diseases risk factors in Brunei Darussalam. J Public Health (Berl). 2020. https://doi.org/10.1007/s10389-020-01287-y.
5. Philippine Heart Association-Council on Hypertension. Philippine Heart Association-Council on Hypertension Report on Survey of Hypertension (Presyon 3): a report on prevalence of hypertension, awareness and treatment profile. Philipp J Cardiol. 2013;41(1):43–8.